8th International Symposium on Age-related Macular Degeneration: Understanding pathogenetic mechanism – towards clinical translation
08. - 09.09.2023, Baden-Baden
Neovascular AMD and Imaging
Meeting Abstract
(23amd18)
[Volltext]
The BIOMAC-Study: modulation of CNV activity in nAMD and anti-VEGF treatment need through systemic factors
Zeitz O, Flesch L, Knecht V, Frentzel DP, Rau S, Rübsam A, Künzel SE, Wolf S, Dreher F, Schuette M, Lange B, Yaspo ML, Lehrach H, Joussen AM[Volltext]
Meeting Abstract
(23amd19)
[Volltext]
Long-term choroidal thickness changes after anti-VEGF treatment for neovascular AMD depending on the type of macular neovascularisation (5-year follow-up)
Abdin AD, Hanifa O, Weinstein I, Munteanu C, Seitz B[Volltext]
Meeting Abstract
(23amd20)
[Volltext]
Short-term results of intravitreal faricimab for refractory nMD
Aljundi W, Munteanu C, Seitz B, Abdin AD[Volltext]
Meeting Abstract
(23amd21)
[Volltext]
Progression of type 1 macular neovascularization into aneurysmal polypoidal choroidal vasculopathy within the pachychoroid spectrum
Siedlecki J, Klaas JE, Keidel LF, Asani B, Luft N, Priglinger SG, Schworm B[Volltext]
Meeting Abstract
(23amd22)
[Volltext]
Preliminary clinical and progression analysis of a prospective cohort study of unilateral nAMD
Cinque F, ten Brink S, Shahabi M, de Breuk A, Heesterbeek T, Klaver C, Hoyng C, Lechanteur Y[Volltext]
